Wealth Quarterback’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-11,214
Closed -$382K 113
2023
Q2
$382K Sell
11,214
-340
-3% -$10.7K 0.26% 75
2023
Q1
$347K Sell
11,554
-2,890
-20% -$89.5K 0.29% 74
2022
Q4
$408K Sell
14,444
-833
-5% -$26.4K 0.34% 69
2022
Q3
$502K Buy
15,277
+248
+2% +$9.11K 0.53% 46
2022
Q2
$473K Buy
+15,029
New +$526K 0.37% 60
2021
Q3
$1.52M Sell
20,741
-712
-3% -$59.7K 1.01% 15
2021
Q2
$1.99M Buy
+21,453
New +$1.82M 1.21% 15
2020
Q4
$580K Buy
+6,215
New +$495K 0.48% 53

Other funds holding ARKG

Wealth Quarterback's ARKG Position: Q3 2023 in Review

Wealth Quarterback sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2023, closing a stake of 11,214 shares — an estimated $382K sold.

Wealth Quarterback first reported a position in ARKG in Q4 2020 and held it in 8 quarters. The position peaked at $1.99M in Q2 2021. 286 funds tracked by Wall St. Rank hold ARKG as of Q3 2023.

  • Wealth Quarterback reported no remaining ARK Genomic Revolution ETF position as of Q3 2023 after selling out during the quarter.
  • Wealth Quarterback sold 11,214 ARK Genomic Revolution ETF shares in Q3 2023, an estimated $382K.
  • Wealth Quarterback first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 8 quarters.
  • Wealth Quarterback's ARK Genomic Revolution ETF position peaked at $1.99M in Q2 2021.
  • 286 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2023.

Based on Wealth Quarterback's 13F filing for Q3 2023, filed 13 Nov 2023.